YK Bioventures Opportunities GP I, LLC

Track

Insider profile

Performance

Overall performance
3.8
Performance over holding periods
3.8
30 days 90 days 120 days
Average return 14% 8.2% 15.1%
Success rate 71% 68% 82%
Transactions
7 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
YK Bioventures Opportunities GP I, LLC's trades of CERo Therapeutics Holdings Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-12-13 2024-12-13
S Sale
5,321 -4.1%
234.73
US$3,057,517 		5,321 -4.1% 234.73 US$3,057,517
2024-12-13 2024-12-12
S Sale
34,890 +42.6%
366.37
US$3,308,168 		34,890 +42.6% 366.37 US$3,308,168
2024-12-13 2024-12-11
S Sale
44,989 -10.8%
160.18
US$2,939,634 		44,989 -10.8% 160.18 US$2,939,634
2024-12-10 2024-12-10
S Sale
1,570,947 -7.7%
0.09
US$141,385 		1,570,947 -7.7% 0.09 US$141,385
2024-12-10 2024-12-09
S Sale
850,543 -4.0%
0.11
US$93,560 		850,543 -4.0% 0.11 US$93,560
2024-12-10 2024-12-06
S Sale
1,236,874 -5.5%
0.12
US$148,425 		1,236,874 -5.5% 0.12 US$148,425
2024-11-14 2024-10-10
S Sale
3,250,000 -12.6%
0.10
US$325,000 		3,250,000 -12.6% 0.10 US$325,000